Modulating endothelial-specific signaling to enhance functional hematopoiesis.
Modulating endothelial-specific signaling to enhance functional hematopoiesis.
批准号:
9149403
负责人:
Jason Mathew Butler
金额:
$41.94万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-09-01 至 2020-06-30
关键词:
AdultAffectApoptoticBackBloodBlood VesselsBone MarrowBone Marrow TransplantationCell CycleCell MaintenanceCell physiologyCellsClinicalClinical TrialsCoculture TechniquesDNADNA DamageDataData SetDevelopmentDoseEndothelial CellsEndotheliumEquilibriumFoundationsGoalsHematological DiseaseHematopoiesisHematopoieticHematopoietic SystemHematopoietic stem cellsHomeostasisImmune systemIn VitroInjuryLaboratoriesLeadLethal Dose 50LifeMaintenanceMetabolicModelingMorbidity - disease rateMusMyelosuppressionNF-kappa BNFKB Signaling PathwayNatural regenerationOrgan Culture TechniquesOutcomeOxidative PhosphorylationPancytopeniaPathway interactionsPlayProductionProtocols documentationRadiationRecoveryRegimenResearch Project GrantsResearch ProposalsRoleSignal PathwaySignal TransductionStem cell transplantStem cellsSystemTechniquesTestingTherapeuticTransgenic MiceTransplantationVascular Systemanaerobic glycolysisbasedesignfitnessin vivoinjuredinsightirradiationloss of functionmetabolic profilemortalitymouse modelnovelnovel strategiesnovel therapeutic interventionnovel therapeuticsparacrinepre-clinicalpromoterregenerativerepairedresearch studyself-renewalstem cell nichetranscriptome sequencing
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Adult hematopoietic stem cells (HSCs) are defined by their ability to undergo self-renewal and
maintain the capacity to generate all types of mature hematopoietic cells within the blood and immune
system. The bone marrow (BM) microenvironment supplies critical pro-hematopoietic signals that regulate
the maintenance of the hematopoietic system. Understanding these signals may lead to the development
of novel strategies to increase the number of HSCs that would be available in a clinical setting to treat a
wide variety of hematological diseases. The overall goal of this research project is to define mechanisms by
which NF-kB signaling in the BM vascular niche regulates the maintenance of the HSC pool during
homeostatic and regenerative conditions. We have recently demonstrated that endothelial cells (ECs) play
an essential role in maintaining HSC homeostasis through activation of the Akt pathway, enabling ECs to
maintain and expand functional HSCs. However, the signaling pathways downstream of Akt responsible for
endowing ECs with the instructional capacity to regulate the self-renewal and differentiation of HSCs are
unknown. We have found that the inhibiting NF-kB signaling in Akt-activated ECs results in robust
expansion of functional mouse HSCs thereby enhancing hematopoietic recovery following
myelosuppression, in part, by protecting the BM microenvironment. Based on these observations, we
hypothesize that the inhibition of NF-kB signaling pathway in BMECs regulates the maintenance of
the HSC pool by protecting the hematopoietic and vascular system from radiation-induced DNA and
metabolic damage. To study the role of NF-kB signaling in BMECs, we will use a transgenic mouse model
in which NF-kB signaling is inhibited under the control of a vascular specific promoter. Utilizing novel
techniques developed in our laboratory that enable us to isolate and cultivate ECs from the BM, we will be
able to test if inhibiting the Akt/NF-kB signaling axis within the vascular niche 1) protects the HSC from
radiation induced DNA and cellular damage, 2) helps maintain and restore the proper metabolic profile
during hematopoietic regeneration, 3) rejuvenates the BM vascular niche and hematopoietic system by
transplanting properly activated BMECs, and 4) enhances the expression of novel pro-hematopoietic factors
that promote homeostatic and regenerative hematopoiesis. These studies will begin to unravel the
mechanisms by which ECs support the balance between HSC self-renewal and differentiation. These
studies will lay the foundation to develop new therapeutic strategies aimed at rejuvenating the HSC niche
and restoring the hematopoietic compartment following myeloablative treatments.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Preserving bone marrow niche integrity and function to rejuvenate aged hematopoietic stem cells
-
批准号:10735925
-
项目类别:
-
资助金额:$65.1万
-
财政年份:2023
-
负责人:Jason Mathew Butler
-
依托单位:
Rejuvenation of aged hematopoietic stem cells and endothelial niches by thrombospondin-1 blockade
-
批准号:10709177
-
项目类别:
-
资助金额:$21.75万
-
财政年份:2022
-
负责人:Jason Mathew Butler
-
依托单位:
Rejuvenation of aged hematopoietic stem cells and endothelial niches by thrombospondin-1 blockade
-
批准号:10634625
-
项目类别:
-
资助金额:$49.57万
-
财政年份:2022
-
负责人:Jason Mathew Butler
-
依托单位:
Rejuvenation of aged hematopoietic stem cells and endothelial niches by thrombospondin-1 blockade
-
批准号:10431964
-
项目类别:
-
资助金额:$35.81万
-
财政年份:2019
-
负责人:Jason Mathew Butler
-
依托单位:
Rejuvenation of aged hematopoietic stem cells and endothelial niches by thrombospondin-1 blockade
-
批准号:10200637
-
项目类别:
-
资助金额:$57.56万
-
财政年份:2019
-
负责人:Jason Mathew Butler
-
依托单位:
Rejuvenation of aged hematopoietic stem cells and endothelial niches by thrombospondin-1 blockade
-
批准号:10026020
-
项目类别:
-
资助金额:$57.56万
-
财政年份:2019
-
负责人:Jason Mathew Butler
-
依托单位:
Modulating signaling pathways in endothelial cells to abate leukemic progression
-
批准号:9893715
-
项目类别:
-
资助金额:$40.51万
-
财政年份:2016
-
负责人:Jason Mathew Butler
-
依托单位:
海外基金